SCHEMBL844884

SCHEMBL844884

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)C3CC3)cc2)cc1)[C@@H]1CCCN1C(=O)C1CC1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
NPC1 O15118 1/20 0.47
LMNA P02545 2/20 0.47
ALDH1A1 P00352 3/20 0.46
MAPK1 P28482 2/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
RHOC P08134 1/20 0.45
RHOA P61586 1/20 0.45
PABPC1 P11940 1/20 0.44
TSHR P16473 1/20 0.44
EP300 Q09472 1/20 0.43
CREBBP Q92793 1/20 0.43
USP2 O75604 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845255 0.96 CYP2C9 (0.47) HTTCYP2C9CYP2C19NPC1LMNA
SCHEMBL845251 0.87 PABPC1 (0.50) HTTCYP2C9CYP2C19NPC1LMNA
SCHEMBL845030 0.86 ALDH1A1 (0.49) HTTCYP2C9CYP2C19NPC1LMNA
SCHEMBL845120 0.84 HPGD (0.47) CYP2C9NPC1LMNAALDH1A1MEN1
SCHEMBL845500 0.83 HPGD (0.51) CYP2C9NPC1LMNAALDH1A1MEN1
SCHEMBL845495 0.83 HPGD (0.51) CYP2C9NPC1LMNAALDH1A1MEN1
SCHEMBL845170 0.83 CYP2C9 (0.47) HTTCYP2C9CYP2C19NPC1LMNA
SCHEMBL28421408 0.83 ALDH1A1 (0.50) HTTCYP2C9CYP2C19NPC1LMNA
SCHEMBL28420335 0.83 ALDH1A1 (0.50) HTTCYP2C9CYP2C19NPC1LMNA
SCHEMBL845258 0.83 MAPK1 (0.60) HTTCYP2C9CYP2C19NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed